Verastem (VSTM) Amortizatization of Intangibles (2014 - 2018)
Verastem (VSTM) posted quarterly Amortizatization of Intangibles of $95000.0 for Q2 2018, up 61.02% year-over-year from $59000.0 in Q2 2017, and up 14.46% quarter-over-quarter from $83000.0 in Q1 2018.
Powered by 
Analysis
Verastem (VSTM) Amortizatization of Intangibles (2014 - 2018) Analysis & Trends
Verastem's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $95000.0 for Q2 2018.
- In Q2 2018, Amortizatization of Intangibles rose 61.02% year-over-year to $95000.0; the TTM figure through Jun 2018 stood at $296000.0 (up 419.3% YoY), while the FY2017 annual figure was $223000.0, up 259.29% from the prior year.
- Amortizatization of Intangibles for Q2 2018 stood at $95000.0, up from $83000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $478000.0 in Q4 2015, with the low at -$80000.0 in Q2 2016.
- The 5-year median for Amortizatization of Intangibles is -$5000.0 (2016), against an average of $24187.5.
- The sharpest annual moves came in 2016 and 2017: Amortizatization of Intangibles sank 99.58% in 2016, then surged 2550.0% in 2017.
- Verastem's Amortizatization of Intangibles stood at -$60000.0 in 2014, then surged by 896.67% to $478000.0 in 2015, then tumbled by 99.58% to $2000.0 in 2016, then soared by 2550.0% to $53000.0 in 2017, then soared by 79.25% to $95000.0 in 2018.
- Business Quant data shows VSTM's Amortizatization of Intangibles at $95000.0 in Q2 2018, $83000.0 in Q1 2018, and $53000.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 95,000.00 |
| Mar 31, 2018 | 83,000.00 |
| Dec 31, 2017 | 53,000.00 |
| Sep 30, 2017 | 65,000.00 |
| Jun 30, 2017 | 59,000.00 |
| Mar 31, 2017 | 46,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | -50,000.00 |
| Jun 30, 2016 | -80,000.00 |
| Mar 31, 2016 | -12,000.00 |
| Dec 31, 2015 | 478,000.00 |
| Sep 30, 2015 | -79,000.00 |
| Jun 30, 2015 | -77,000.00 |
| Mar 31, 2015 | -58,000.00 |
| Dec 31, 2014 | -60,000.00 |
| Sep 30, 2014 | -78,000.00 |